BMRN 8-K 2026-10-06
BIOMARIN PHARMACEUTICAL INC (BMRN) 8-K dated 2026-10-06 — accession 0001048477-26-000019. This URL is the filing, not the BMRN hub.
BIOMARIN PHARMACEUTICAL INC (BMRN) is a biotechnology company listed on NASDAQ.
BMRN to acquire platform ($283M)
Cached items: 2.02. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.
Latest reported BMRN revenue for 2025-12-31 was $3.22B. Net income was $348.9M. Revenue was up 12.9% from 2024-12-31 to 2025-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 142.4.
Not investment advice. The BMRN SEC hub lists recent forms. The stock page is the research view.
- Guidance
- expects its GAAP and non-GAAP financial results for the third quarter of 2026 to include pre-tax charges of approximately $283
- Deal
- $283M
Why it matters
- expects its GAAP and non-GAAP financial results for the third quarter of 2026 to include pre-tax charges of approximately $283
- Transaction value about $283M